On March 1, 2023, Senator Mike Crapo (R-ID), along with other Senate Finance Committee Republicans, sent a letter to Xavier…
On February 24, 2023, the DEA released its proposed rules for prescribing controlled medications via telemedicine after the COVID-19 public…
On January 30, 2023, the Biden Administration announced that the COVID-19 public health emergency (PHE) will end on May 11,…
A recent survey conducted by Ipsos, reported finding that 45 percent of American women skip preventative care services like check-ups,…
In 2022, Texas passed and implemented a gold-card law to help reduce health care providers prior authorization administrative burdens. To…
On January 26, 2023, the Food and Drug Administration (Agency) announced that the existing regulatory frameworks are not appropriate for…
The National Institutes of Health (NIH) demonstrated its support for a broad range of research on cannabis, cannabinoids, and related…
In January 2023, Senator Breslin and Assemblyman McDonald reintroduced four step-therapy bills that would create additional protections for patients in…
On January 23, 2023, the Food and Drug Administration (FDA) published a final guidance for industry, “Cannabis and Cannabis-Derived Compounds:…
On January 17, 2023, the Institute for Clinical and Economic Review (ICER) published its second annual “Barriers to Fair Access”…